Since the discovery that ATRX is often lost in ALT-(alternative lengthening of telomeres) positive tumours (3), studies on the molecular mechanism by which ATRX suppresses the ALT pathway in cancer (4) far outnumber those on its roles in development. This evidence concerns the gene ATRX and cancer.